Marshall Wace North America’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-27,958
| Closed | -$979K | – | 1274 |
|
|
2020
Q3 | $979K | Buy |
27,958
+7,252
| +35% | +$254K | 0.01% | 810 |
|
|
2020
Q2 | $1.11M | Buy |
+20,706
| New | +$1.11M | 0.01% | 731 |
|
|
2019
Q4 | – | Sell |
-419,574
| Closed | -$13.6M | – | 1261 |
|
|
2019
Q3 | $13.6M | Buy |
419,574
+316,183
| +306% | +$10.2M | 0.08% | 212 |
|
|
2019
Q2 | $5.16M | Buy |
+103,391
| New | +$5.16M | 0.03% | 355 |
|
|
2019
Q1 | – | Sell |
-6,684
| Closed | -$308K | – | 1522 |
|
|
2018
Q4 | $308K | Sell |
6,684
-204,385
| -97% | -$9.42M | ﹤0.01% | 883 |
|
|
2018
Q3 | $16.3M | Sell |
211,069
-84,689
| -29% | -$6.53M | 0.11% | 157 |
|
|
2018
Q2 | $24.9M | Sell |
295,758
-43,036
| -13% | -$3.62M | 0.14% | 172 |
|
|
2018
Q1 | $27.7M | Buy |
338,794
+103,969
| +44% | +$8.5M | 0.14% | 167 |
|
|
2017
Q4 | $13.4M | Sell |
234,825
-3,556
| -1% | -$203K | 0.07% | 313 |
|
|
2017
Q3 | $16M | Buy |
+238,381
| New | +$16M | 0.1% | 258 |
|
|
2013
Q4 | $361K | Sell |
15,054
-2,657
| -15% | -$63.7K | 0.01% | 568 |
|
|
2013
Q3 | $495K | Buy |
+17,711
| New | +$495K | 0.02% | 447 |
|